My name is Barney Hill.

I am focused on making genetic medicines accessible for the 300M individuals with a disease-causing mutation in one of their genes.



  

My thesis is based on the belief that as RNA therapeutics are the simplest form of drug we have, they should be the simplest to model.

In the first year of my DPhil, I showed that we can ~5x reduce the initial screening burden of antisense oligonucleotides with an accurate model of how effectively they cleave genes in cells (see: Accurately modelling RNase H-mediated antisense oligonucleotide efficacy).



  

I am now working on a unified antisense oligonucleotide model to predict outcomes across the entire preclinical pipeline, with the goal of substantially reducing preclinical development costs.

I also help run In Silico, a biomolecular design meet-up in London [#001, #002, #003, #004]. If you are working in this space, I would love to meet.


Side projects


Friends list

Monty Liberty Nina Chris Jakub Yuyang Kindred Oliver Elston James David

Have an issue with not being here? Raise it.